Physician profile
Xiaowei Xu
NPI 1639115470
$34,919.66
in general payments reported to CMS, 2019-2025
4 companies · $8,583 in 2025
The $8,583 reported for 2025 was more than what 89% of Anatomic Pathology providers received nationally (typical 2025 total: $110).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $1,925 · 2025: $8,583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,040 · Travel and Lodging: $1,269 · Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,040.00 |
| Travel and Lodging | $1,269.49 |
| Food and Beverage | $273.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $24,411.96 | 2019 | |
| Merck Sharp & Dohme LLC | $8,582.70 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,925.00 | 2020 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaowei Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.